Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

NCT04478123 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
HDT-AHCT

Interventions

DRUG: Romiplostim

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]